SCHEMBL6214432

SCHEMBL6214432

COc1cc2ncn(-c3cc(OCCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 20/20 0.84
PLK3 Q9H4B4 4/20 0.84
CDK2 P24941 2/20 0.68
IKBKE Q14164 1/20 0.68
PLK4 O00444 1/20 0.67
AURKA O14965 1/20 0.67
JAK2 O60674 1/20 0.67
RPS6KA5 O75582 1/20 0.67
MAP4K4 O95819 1/20 0.67
EGFR P00533 1/20 0.67
ERBB2 P04626 1/20 0.67
NTRK1 P04629 1/20 0.67
LCK P06239 1/20 0.67
CSF1R P07333 1/20 0.67
PDGFRB P09619 1/20 0.67
ALOX5 P09917 1/20 0.67
KIT P10721 1/20 0.67
FGFR1 P11362 1/20 0.67
SRC P12931 1/20 0.67
FLT1 P17948 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gsk-204925A SCHEMBL4367870 0.87 PLK1 (1.00) PLK1PLK3CDK2PLK4AURKA
SCHEMBL6214929 0.87 PLK1 (0.68) PLK1PLK3MAP4K4CSF1RKDR
SCHEMBL5058253 0.85 PLK1 (0.82) PLK1PLK3CDK2IKBKEPLK4
SCHEMBL5062103 0.85 PLK1 (1.00) PLK1PLK3CDK2PLK4AURKA
SCHEMBL4033812 0.84 PLK1 (0.81) PLK1PLK3CDK2PLK4AURKA
SCHEMBL14050260 0.83 PLK1 (0.86) PLK1PLK3CDK2PLK4AURKA
SCHEMBL5058276 0.82 PLK1 (0.82) PLK1PLK3CDK2PLK4AURKA
SCHEMBL5058358 0.82 PLK1 (0.81) PLK1PLK3CDK2PLK4AURKA
SCHEMBL5062225 0.82 PLK1 (1.00) PLK1PLK3CDK2PLK4AURKA
SCHEMBL4034533 0.82 IKBKE (0.67) PLK1PLK3IKBKE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546137-A1 BENZIMIDAZOL-1-YL-THIOPHENE COMPOUNDS FOR THE TREATMENT OF CANCER SmithKline Beecham Corporation (US) 2005-06-29 EP disclosed
WO-2004014899-A1 THIOPHENE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2004-02-19 WO disclosed